Pharma - visiongain

pharma

Pharma Business Daily: Each issue of the Pharma Business Daily newsletter focuses on the latest market information. Delivered directly to your Inbox or available via our website, keep abreast of whatever you need to know, whenever you need to know it. 24/7, 365 days a year - it really is that simple. With over 25 breaking stories every day, never again will any of your colleagues be aware of news you aren't.

CONSULTANCY

With unparalleled knowledge of the markets we study, our consultants provide quality research specifically for you. We assist our clients in researching mergers and acquisitions, accessing new markets, competitor analysis, and negotiating and structuring deals. We can also advise clients strategically on advertising, marketing or PR.

...see all

Drug Delivery Technologies: Commercial Prospects 2012-2022
What does the future hold for drug delivery technologies? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions. This decade, many commercial opportunities for improved drug delivery exist. You discover sales predictions to 2022 at world market, submarket, application and national level.
...more details
Needle-Free Delivery: Technology and Market 2012-2022
The technology and devices for needle-free delivery of drugs/vaccines has been available in the market since several decades. Although their market penetration has been low, the recent years have seen an increase in adoption, driven by the need for pain free delivery. Currently, the market for needle-free delivery devices is dominated by small medical device companies and academic researchers. These small scale companies are developing innovative needle-free delivery technologies, with the pharmaceutical companies entering into partnership with the device developers for using the technology for delivery of the company's drug.
...more details
Cell-Based Assays: World Market Prospects 2012-2022
What does the future hold for cell-based assays in pharma? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions. Our study analyses products and services for cell-based testing. It covers activities of product developers and pre-clinical contract research organisations. You discover sales predictions to 2022 at world market, main submarket and national levels.
...more details

Upcoming CONFERENCES

...see all

Biobanking 2012
9th - 10th February 2012, Thistle City Barbican, Central Street, Clerkenwell, London, EC1V 8DS, UK
As researchers strive to develop more personalised medicines, the acquisition of high quality biospecimens is vital. This is reflected in the estimation that the biobanking market will be worth $19.13 bn by 2015. Harmonising biobank operations with better communication networks and global standardisation is imperative. The biobanking and biomolecular resources research infrastructure's new model for research estimates they will have approximately 200 biobanks operating across Europe by early 2012, complying with clearly defined responsibilities, quality standards and common procedures.
...more details
2nd Lyophilization Americas
6th - 8th March 2012, The Seaport Hotel, Boston, USA
With over 130 products on the market worth $50bn, biologicals and biopharmaceuticals remain the fastest growing segment amongst novel pharmaceutical entities today. Mirroring this trend the market for lyophilizing compounds such as biologicals and biopharmaceuticals is currently approaching 200 million units and it is set to continue its year-on-year double digit growth. The lyophilisation market is expected to achieve significant growth from 2011 to 2021, owing primarily to greater demand for injectable biotech drugs and vaccine market expansion caused by the entry of new products and technologies.
...more details
10th Biosimilars Americas
13th - 15th March 2012, The Seaport Hotel, Boston, USA
Biologics constitutes a major share of expenditure in the USA and globally. It is one of the fastest growing sectors of the pharmaceutical industry which corresponds to over 15% of the total pharmaceutical market. There is a large and potentially lucrative demand for lower cost biological drugs worldwide. With favourable regulatory developments, the biosimilar sector should pick up significantly, however, forming an important developing pharma market.
...more details

NEWSLETTER

CONSULTANCY

Latest REPORTS

Drug Delivery Technologies: Commercial Prospects 2012-2022

Needle-Free Delivery: Technology and Market 2012-2022

Cell-Based Assays: World Market Prospects 2012-2022

Upcoming CONFERENCES

Biobanking 2012

2nd Lyophilization Americas

10th Biosimilars Americas